The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 17, 1987

Filed:

Aug. 01, 1984
Applicant:
Inventors:

Arthur Friedman, Churchville, PA (US);

E Dale Lehman, Lansdale, PA (US);

William J McAleer, Ambler, PA (US);

Ted F Schaefer, Collegeville, PA (US);

Edward M Scolnick, Wynnewood, PA (US);

D Eugene Wampler, Harleysville, PA (US);

Assignee:

Merck & Co., Inc., Rahway, NJ (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K / ; C08B / ; C12N / ; C07K / ;
U.S. Cl.
CPC ...
530371 ; 530395 ; 530417 ; 530415 ; 530806 ; 530826 ; 424 89 ; 436820 ; 210635 ; 2105021 ; 2101982 ; 435-5 ; 435 68 ; 435 70 ; 4351723 ; 435235 ; 435239 ; 435255 ; 435803 ;
Abstract

The surface antigen protein of human Hepatitis B virus is synthesized in Saccharomyces cerevisiae as a 23,000-26,000 dalton polypeptide, essentially free of intermolecular disulfide bonds. This antigen is a poor immunogen in animals and man. No prior precedent or method exists for efficiently converting the non-disulfide bonded antigen to a fully intermolecular disulfide bonded particle. We describe the first example of such a conversion in vitro and show that the act of this conversion enhances the immunogenicity of the antigen about 10-fold. The in vitro conversion makes practical the production of hepatitis B surface antigen from microorganisms using recombinant DNA methods.


Find Patent Forward Citations

Loading…